Clinical Trial Update: Immunotherapy With IFx-Hu2.0 Vaccine for Advanced Non-melanoma Skin Cancers [Phase 1]

View source ↗

Summary

Phase 1 clinical trial update on the IFx-Hu2.0 vaccine for advanced non-melanoma skin cancers, including Merkel cell carcinoma and cutaneous squamous cell carci…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cutaneous Squamous Cell Carcinoma
• Merkel Cell Carcinoma
• Non-melanoma Skin Cancer

Drugs mentioned

• IFx-Hu2.0 vaccine (IFx-Hu2.0)

Snippet

Sponsor: TuHURA Biosciences, Inc. | Conditions: Merkel Cell Carcinoma, Cutaneous Squamous Cell Carcinoma | Phase 1 | Status: COMPLETED